802
Views
58
CrossRef citations to date
0
Altmetric
Review

Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016)

, , , &
Pages 217-225 | Received 26 Jul 2016, Accepted 05 Oct 2016, Published online: 22 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Charikleia S. Batsika, Anna-Dimitra D. Gerogiannopoulou, Christiana Mantzourani, Sofia Vasilakaki & George Kokotos. (2021) The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases. Expert Opinion on Drug Discovery 16:11, pages 1287-1305.
Read now
Sofia Vasilakaki, Johannes Kraml, Michael Schauperl, Klaus R. Liedl & George Kokotos. (2021) Hydration thermodynamics of cytosolic phospholipase A2 GIVA predict its membrane-associated parts and its highly hydrated binding site. Journal of Biomolecular Structure and Dynamics 39:3, pages 953-959.
Read now
J. Abhithaj, K. G. Arun, C. S. Sharanya, M. Haridas & E. Jayadevi Variyar. (2019) Isozymes inhibited by active site blocking: versatility of calcium indifferent hesperidin binding to phospholipase A2 and its significance. Journal of Receptors and Signal Transduction 39:1, pages 60-66.
Read now
Jiangyong Gu, Li Li, Dongmei Wang, Wei Zhu, Ling Han, Ruizhi Zhao, Xiaojie Xu & Chuanjian Lu. (2018) Deciphering metabonomics biomarkers-targets interactions for psoriasis vulgaris by network pharmacology. Annals of Medicine 50:4, pages 323-332.
Read now
Anastasia Psarra, Aikaterini Nikolaou, Maroula G Kokotou, Dimitris Limnios & George Kokotos. (2017) Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review. Expert Opinion on Therapeutic Patents 27:9, pages 1047-1059.
Read now

Articles from other publishers (53)

Guilherme H.M. Salvador, Êmylle K.R. Pinto, Paula L. Ortolani, Consuelo L. Fortes-Dias, Walter L.G. Cavalcante, Andreimar M. Soares, Bruno Lomonte, Matthew R. Lewin & Marcos R.M. Fontes. (2023) Structural basis of the myotoxic inhibition of the Bothrops pirajai PrTX-I by the synthetic varespladib. Biochimie 207, pages 1-10.
Crossref
Karuppiah Prakash Shyam, Venkatesan Ramya, Shaik Nadiya, Abhinav Parashar & Daniel A. Gideon. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 271 307 .
Diptimayee Das, C. Cynthia, Surajit Pathak & Antara Banerjee. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 63 85 .
Ana Gabriela García-Arellano, Luis Fernando Calderón-Soto, Elsa Pereyra-Laguna, Lorena Amaya-Delgado & Enrique J. Herrera-López. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 335 357 .
Angshuman Bagchi. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 211 218 .
Manikkam Rajalakshmi, Periyasamy Vijayalakshmi & Sabapathy Indu. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 15 38 .
K.J. Spandana & N. Bhagya. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 221 227 .
K.J. Spandana & N. Bhagya. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 93 107 .
Varnavas D. Mouchlis & Edward A. Dennis. (2022) Membrane Association Allosterically Regulates Phospholipase A 2 Enzymes and Their Specificity . Accounts of Chemical Research 55:23, pages 3303-3311.
Crossref
Daniele De Luca, Alejandro Alonso & Chiara Autilio. (2022) Bile acid-induced lung injury: update of reverse translational biology. American Journal of Physiology-Lung Cellular and Molecular Physiology 323:1, pages L93-L106.
Crossref
Natascha Berger, Hanna Allerkamp & Christian Wadsack. (2022) Serine Hydrolases in Lipid Homeostasis of the Placenta-Targets for Placental Function?. International Journal of Molecular Sciences 23:12, pages 6851.
Crossref
Edward A. Dennis. (2022) Allosteric regulation by membranes and hydrophobic subsites in phospholipase A2 enzymes determine their substrate specificity. Journal of Biological Chemistry 298:5, pages 101873.
Crossref
Wei Wu, Wen-Xuan Li & Chun-Hong Huang. (2022) Phospholipase A2, a nonnegligible enzyme superfamily in gastrointestinal diseases. Biochimie 194, pages 79-95.
Crossref
Sanjay Mishra, Manish Charan, Rajni Kant Shukla, Pranay Agarwal, Swati Misri, Ajeet K. Verma, Dinesh K. Ahirwar, Jalal Siddiqui, Kirti Kaul, Neety Sahu, Kunj Vyas, Ayush Arpit Garg, Anum Khan, Wayne O. Miles, Jonathan W. Song, Nidhi Bhutani & Ramesh K. Ganju. (2022) cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Daniele De Luca & Chiara Autilio. (2021) Strategies to protect surfactant and enhance its activity. Biomedical Journal 44:6, pages 654-662.
Crossref
Shuai Shao, Jiaoling Chen, William R. Swindell, Lam C. Tsoi, Xianying Xing, Feiyang Ma, Ranjitha Uppala, Mrinal K. Sarkar, Olesya Plazyo, Allison C. Billi, Rachael Wasikowski, Kathleen M. Smith, Prisca Honore, Victoria E. Scott, Emanual Maverakis, J. Michelle Kahlenberg, Gang Wang, Nicole L. Ward, Paul W. Harms & Johann E. Gudjonsson. (2021) Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight 6:20.
Crossref
Qiangzhe Zhang, Julia Zhou, Jiarong Zhou, Ronnie H. Fang, Weiwei Gao & Liangfang Zhang. (2021) Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis. Nature Communications 12:1.
Crossref
Elizabeth D. Kim, Catherine D. Kim, Joseph Chaney & Sunyoung Kim. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III 27 43 .
Sang-Chul Kim & Xuemin Wang. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III 744 757 .
Mimica-Dukić Neda, Ivana Beara, Tamara Vojnović & Cvejić Jelena Helene. 2021. Food Bioactives and Health. Food Bioactives and Health 269 305 .
Ryung Rae Kim, Zheng Chen, Timothy J. Mann, Karine Bastard, Kieran F. Scott & W. Bret Church. (2020) Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2. Molecules 25:19, pages 4459.
Crossref
László Potor, Katalin Éva Sikura, Hajnalka Hegedűs, Dávid Pethő, Zsuzsa Szabó, Zsuzsa M Szigeti, István Pócsi, György Trencsényi, Dezső Szikra, Ildikó Garai, Tamás Gáll, Zsolt Combi, János Kappelmayer, György Balla & József Balla. (2020) The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation. International Journal of Molecular Sciences 21:13, pages 4746.
Crossref
Daniele De Luca, Shivani Shankar-Aguilera, Chiara Autilio, Roberto Raschetti, Luca Vedovelli, Catherine Fitting, Christine Payré, Louise Jeammet, Jesus Perez-Gil, Paola E. Cogo, Virgilio P. Carnielli, Gérard Lambeau & Lhousseine Touqui. (2020) Surfactant-secreted phospholipase A 2 interplay and respiratory outcome in preterm neonates . American Journal of Physiology-Lung Cellular and Molecular Physiology 319:1, pages L95-L104.
Crossref
Qiangzhe Zhang, Ronnie H. Fang, Weiwei Gao & Liangfang Zhang. (2020) A Biomimetic Nanoparticle to “Lure and Kill” Phospholipase A2. Angewandte Chemie International Edition 59:26, pages 10461-10465.
Crossref
Qiangzhe Zhang, Ronnie H. Fang, Weiwei Gao & Liangfang Zhang. (2020) A Biomimetic Nanoparticle to “Lure and Kill” Phospholipase A2. Angewandte Chemie 132:26, pages 10547-10551.
Crossref
Giorgos S. Koutoulogenis, Maroula G. Kokotou, Daiki Hayashi, Varnavas D. Mouchlis, Edward A. Dennis & George Kokotos. (2020) 2-Oxoester Phospholipase A2 Inhibitors with Enhanced Metabolic Stability. Biomolecules 10:3, pages 491.
Crossref
Thais A. Sales, Silvana Marcussi & Teodorico C. Ramalho. (2020) Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018. Current Medicinal Chemistry 27:3, pages 477-497.
Crossref
A. J. Feuerherm, E. A. Dennis & B. Johansen. (2019) Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis. Arthritis Research & Therapy 21:1.
Crossref
Guilherme H. M. Salvador, Antoniel A. S. Gomes, Wendy Bryan-Quirós, Julián Fernández, Matthew R. Lewin, José María Gutiérrez, Bruno Lomonte & Marcos R. M. Fontes. (2019) Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920). Scientific Reports 9:1.
Crossref
Hye Jin Yoo, Keum Ji Jung, Minkyung Kim, Minjoo Kim, Minsik Kang, Sun Ha Jee, Yoonjeong Choi & Jong Ho Lee. (2019) Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Frontiers in Physiology 10.
Crossref
Ronghan Liu, Yuehong Chen, Wenyu Fu, Shuya Wang, Yazhou Cui, Xiangli Zhao, Zi-Ning Lei, Aubryanna Hettinghouse, Jody Liu, Chao Wang, Chen Zhang, Yufei Bi, Guozhi Xiao, Zhe-Sheng Chen & Chuan-ju Liu. (2019) Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis. Annals of the Rheumatic Diseases 78:11, pages 1524-1535.
Crossref
Hanna Maja Tunset, Astrid Jullumstrø Feuerherm, Linn-Karina Myrland Selvik, Berit Johansen & Siver Andreas Moestue. (2019) Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells. International Journal of Molecular Sciences 20:19, pages 4800.
Crossref
Yu-pei Guo, Bei-sha Tang, Hong-li Liu, Juan-juan Huang, Qian Xu, Qi-ying Sun, Xin-xiang Yan & Ji-feng Guo. (2019) Impaired iPLA2β activity affects iron uptake and storage without iron accumulation: An in vitro study excluding decreased iPLA2β activity as the cause of iron deposition in PLAN. Brain Research 1712, pages 25-33.
Crossref
John Turk, Tayleur D. White, Alexander J. Nelson, Xiaoyong Lei & Sasanka Ramanadham. (2019) iPLA2β and its role in male fertility, neurological disorders, metabolic disorders, and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:6, pages 846-860.
Crossref
Aikaterini Nikolaou, Maroula G. Kokotou, Sofia Vasilakaki & George Kokotos. (2019) Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:6, pages 941-956.
Crossref
Joost P. Schanstra, Trang T.D. Luong, Manousos Makridakis, Sophie Van Linthout, Vasiliki Lygirou, Agnieszka Latosisnska, Ioana Alesutan, Beate Boehme, Nadeshda Schelski, Dirk Von Lewinski, William Mullen, Stuart Nicklin, Christian Delles, Guylène Feuillet, Colette Denis, Florian Lang, Burkert Pieske, Jean-Loup Bascands, Harald Mischak, Jean-Sebastien Saulnier-Blache, Jakob Voelkl, Antonia Vlahou & Julie Klein. (2019) Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment. JCI Insight 4:10.
Crossref
Shengde Zhang, Yang Li, Zijian Qin, Guipin Tu, Guang Chen & Aixia Yan. (2019) SAR study on inhibitors of GIIA secreted phospholipase A 2 using machine learning methods . Chemical Biology & Drug Design 93:5, pages 666-684.
Crossref
Christina Dedaki, Maroula G. Kokotou, Varnavas D. Mouchlis, Dimitris Limnios, Xiaoyong Lei, Carol T. Mu, Sasanka Ramanadham, Victoria Magrioti, Edward A. Dennis & George Kokotos. (2019) β-Lactones: A Novel Class of Ca 2+ -Independent Phospholipase A 2 (Group VIA iPLA 2 ) Inhibitors with the Ability To Inhibit β-Cell Apoptosis . Journal of Medicinal Chemistry 62:6, pages 2916-2927.
Crossref
Austin Trotter, Emily Anstadt, Robert B. Clark, Frank Nichols, Alok Dwivedi, Koko Aung & Jorge L. Cervantes. (2019) The role of phospholipase A2 in multiple Sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 27, pages 206-213.
Crossref
Lei Yang & Haiyan Zhang. (2018) Expression of Cytosolic Phospholipase A2 Alpha in Glioblastoma Is Associated With Resistance to Chemotherapy. The American Journal of the Medical Sciences 356:4, pages 391-398.
Crossref
Wanyeon Kim, Beomseok Son, Sungmin Lee, Hyunhee Do & BuHyun Youn. (2018) Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy. Cancer and Metastasis Reviews 37:2-3, pages 213-225.
Crossref
Anastasia Psarra, Maroula G. Kokotou, Gerasimia Galiatsatou, Varnavas D. Mouchlis, Edward A. Dennis & George Kokotos. (2018) Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A 2 (GIVA cPLA 2 ) . ACS Omega 3:8, pages 8843-8853.
Crossref
Tommaso C. Bulfone, Stephen P. Samuel, Philip E. Bickler & Matthew R. Lewin. (2018) Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite. Journal of Tropical Medicine 2018, pages 1-10.
Crossref
Fabrizio Giordanetto, Laurent Knerr, Peter Nordberg, Daniel Pettersen, Nidhal Selmi, Hans-Georg Beisel, Hannah de la Motte, Åsa Månsson, Mikael Dahlström, Johan Broddefalk, Gabrielle Saarinen, Fredrik Klingegård, Eva Hurt-Camejo, Birgitta Rosengren, Johannes Wikström, Maria Wågberg, Johan Brengdahl, Mattias Rohman, Jenny Sandmark, Tomas Åkerud, Robert G. Roth, Frank Jansen & Marie Ahlqvist. (2018) Design of Selective sPLA 2 -X Inhibitor (−)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1 H -indol-1-yl]pyridine-2-yl}propanoic Acid . ACS Medicinal Chemistry Letters 9:7, pages 600-605.
Crossref
Laurent Knerr, Fabrizio Giordanetto, Peter Nordberg, Daniel Pettersen, Nidhal Selmi, Hans-Georg Beisel, Hannah de la Motte, Thomas Olsson, Tim D. J. Perkins, Margareta Herslöf, Åsa Månsson, Mikael Dahlström, Ingemar Starke, Johan Broddefalk, Gabrielle Saarinen, Fredrik Klingegård, Eva Hurt-Camejo, Birgitta Rosengren, Johan Brengdahl, Frank Jansen, Mattias Rohman, Jenny Sandmark, Kenth Hallberg, Tomas Åkerud, Robert G. Roth & Marie Ahlqvist. (2018) Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A 2 Type X (sPLA 2 -X) Inhibitors . ACS Medicinal Chemistry Letters 9:7, pages 594-599.
Crossref
Andrea Huwiler & Uwe Zangemeister-Wittke. (2018) The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. Pharmacology & Therapeutics 185, pages 34-49.
Crossref
Alessandra Bragonzi, Hamed Horati, Lauren Kerrigan, Nicola Ivan Lorè, Bob J. Scholte & Sinéad Weldon. (2018) Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease. Journal of Cystic Fibrosis 17:2, pages S40-S45.
Crossref
Sofia Vasilakaki, Oleksandr Pastukhov, Thomas Mavromoustakos, Andrea Huwiler & George Kokotos. (2018) Small Peptides Able to Suppress Prostaglandin E2 Generation in Renal Mesangial Cells. Molecules 23:1, pages 158.
Crossref
Ansgar Flammersfeld, Christina Lang, Antje Flieger & Gabriele Pradel. (2018) Phospholipases during membrane dynamics in malaria parasites. International Journal of Medical Microbiology 308:1, pages 129-141.
Crossref
Qiufeng Liu, Fubao Huang, Xiaojing Yuan, Kai Wang, Yi Zou, Jianhua Shen & Yechun Xu. (2017) Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. Journal of Medicinal Chemistry 60:24, pages 10231-10244.
Crossref
Cheng Yang Ng, Srinivasaraghavan Kannan, Yong Jun Chen, Francis Chee Kuan Tan, Wee Yong Ong, Mei Lin Go, Chandra S. Verma, Chian-Ming Low & Yulin Lam. (2017) A New Generation of Arachidonic Acid Analogues as Potential Neurological Agent Targeting Cytosolic Phospholipase A2. Scientific Reports 7:1.
Crossref
Reza Nemati, Christopher Dietz, Emily J. Anstadt, Jorge Cervantes, Yaling Liu, Floyd E. Dewhirst, Robert B. Clark, Sydney Finegold, James J. Gallagher, Michael B. Smith, Xudong Yao & Frank C. Nichols. (2017) Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis. Journal of Lipid Research 58:10, pages 1999-2007.
Crossref
Maroula G. Kokotou, Gerasimia Galiatsatou, Victoria Magrioti, Giorgos Koutoulogenis, Efrosini Barbayianni, Dimitris Limnios, Varnavas D. Mouchlis, Banita Satpathy, Aaron Navratil, Edward A. Dennis & George Kokotos. (2017) 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2. Scientific Reports 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.